Science & Enterprise subscription

Follow us on Twitter

  • National Science Foundation is funding a new system that uses artificial intelligence to find optimal combinations… https://t.co/jbZAJqQpmT
    about 14 hours ago
  • New post on Science and Enterprise: NSF Funds AI Covid-19 Drug Combo Simulation https://t.co/j7DsIncCUk #Science #Business
    about 14 hours ago
  • A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for… https://t.co/CVwEr6dEoU
    about 14 hours ago
  • New post on Science and Enterprise: Gene-Edited Transplant Organ Company Raises $125M https://t.co/UYlUcA8Z5X #Science #Business
    about 18 hours ago
  • A home Covid-19 test is being evaluated with a smartphone app, as part of an NIH program to quickly develop Covid-1… https://t.co/82gYsU3rvr
    about 2 days ago

Please share Science & Enterprise

Infographic – States Reporting SARS-CoV-2 Variants

Covid-19 variations in states

The most widespread variant so far in the U.S. is B.1.1.7, first discovered in the U.K. . . . → Read More: Infographic – States Reporting SARS-CoV-2 Variants

20 Precision Meds Approved by FDA in 2020

Syringe, pills, capsules

A report by a group advocating for precision medicine notes that the Food and Drug Administration approved 20 new personalized drugs and biologics in 2020. . . . → Read More: 20 Precision Meds Approved by FDA in 2020

AI Designs Better Gene Therapy Delivery Viruses

Adeno-associated virus

An academic-industry team used machine learning to design more effective variations of common benign viruses that deliver gene therapies. . . . → Read More: AI Designs Better Gene Therapy Delivery Viruses

Immune Response Shown in Alzheimer’s Vaccine

Brain activity graphic

Results from a clinical trial show an experimental vaccine produces antibodies for breaking up harmful brain deposits in people with early Alzheimer’s disease. . . . → Read More: Immune Response Shown in Alzheimer’s Vaccine

AbbVie Licenses Engineered Crispr Cell Process

Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies. . . . → Read More: AbbVie Licenses Engineered Crispr Cell Process

FDA Clears Covid-19 Dual-Antibody Therapy

SARS-Cov-2 viruses

The Food and Drug Administration granted an emergency authorization for a combination of two synthetic antibodies to treat non-hospitalized Covid-19 infections. . . . → Read More: FDA Clears Covid-19 Dual-Antibody Therapy

Smartwatch Shown to Offer Early Covid-19 Warning

Apple Watch

A study shows heart rate data captured by an Apple watch can provide an early warning of impending Covid-19 infections, even before a positive test. . . . → Read More: Smartwatch Shown to Offer Early Covid-19 Warning

Biotech, UK Govt to Design Covid-19 Variant Vaccines

Vaccine vials

A biotechnology company and a U.K. government agency agreed to quickly develop and produce vaccines to protect against emerging Covid-19 viral mutations. . . . → Read More: Biotech, UK Govt to Design Covid-19 Variant Vaccines

Apple Watch Helps Personalize Parkinson’s Care

Operating a smart watch

A new study shows an Apple watch can capture data on tremors experienced by people with Parkinson’s disease to help provide more precise care. . . . → Read More: Apple Watch Helps Personalize Parkinson’s Care

Engineered Cell Therapy Company Issues $588M IPO

NASDAQ share price display

A company developing regenerative therapies with engineered stem cells for cancer and other diseases is raising $587.5 million in its initial public offering or IPO. . . . → Read More: Engineered Cell Therapy Company Issues $588M IPO